Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
4Customers
2Debt Items
8Related Chains
Source-Backed Evidence Depth
Hepion Pharmaceuticals, Inc. (CTRVP) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
8Total relationships
2Distinct source URLs
2High confidence
0.765Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
hs of treatment with once daily oral rencofilstat administered to NASH subjects with stage 3 or greater fibrosis. All additional secondary efficacy and safety endpoints were also met. These observati…
Reciprocal relationship from AUPH graph: Reciprocal relationship from CTRVP graph: hs of treatment with once daily oral rencofilstat administered to NASH subjects with stage 3 or greater fibrosis. Al…
hs of treatment with once daily oral rencofilstat administered to NASH subjects with stage 3 or greater fibrosis. All additional secondary efficacy and safety endpoints were also met. These observati…
Reciprocal relationship from AUPH graph: Reciprocal relationship from CTRVP graph: hs of treatment with once daily oral rencofilstat administered to NASH subjects with stage 3 or greater fibrosis. Al…
and 2022 are related to our foreign operations. Contingencies In the normal course of business, we are subject to loss contingencies, such as legal proceedings and claims arising out of our business …
Reciprocal relationship from HEPA graph: Reciprocal relationship from CTRVP graph: Reciprocal relationship from HEPA graph: Reciprocal relationship from CTRVP graph: and 2022 are related to our forei…
Hepion Pharmaceuticals, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CTRVP-DEBT-8919
Warrants outstanding: 553846
90%
xbrl warrant detail from xbrl 2025-01-23.
CTRVP-DEBT-8920
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
Hepion Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Hepion Pharmaceuticals, Inc..
Hepion Pharmaceuticals, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Hepion Pharmaceuticals, Inc..
Hepion Pharmaceuticals, Inc. Extended Supply Chain Network
